期刊文献+

骨桥蛋白和环氧化酶2在声门上型喉癌中的表达及临床意义 被引量:1

Expressions and clinical significance of osteopontin and COX-2 in supraglottic laryngeal squamous cell carcinoma
原文传递
导出
摘要 目的探讨骨桥蛋白(OPN)和环氧化酶2(COX-2)在声门上型喉癌中的表达及意义。方法免疫组化法检测48例声门上型喉癌(A组)和癌旁组织(B组)中OPN和COX-2的表达。结果 A组OPN和COX-2表达均高于B组(89.58%vs.20.83%和85.42%vs.16.67%)(P<0.05)。OPN的表达与肿瘤分期、分级以及淋巴结转移密切相关(P<0.05);COX-2的表达与肿瘤分期、分级密切相关(P<0.05)。OPN和COX-2在声门上型喉癌组织中的表达呈正相关(P<0.05)。结论 OPN和COX-2有可能成为声门上型喉癌诊断的标志物和潜在治疗靶点。 Objective To explore the expressions and clinical significance of osteopontin(OPN) and cyclooxygenase-2 (COX-2) in supraglottic laryngeal squamous cell carcinoma. Methods The expressions of OPN and COX-2 were detected with immunohistochemistry in 48 cases of supraglottic laryngeal carcinoma(group A) and tumor-adjacent tissues(group B). Results The expression rates of OPN and COX-2 were higher in group A than those in group B(89. 58% vs. 20. 83% and 85.42% vs. 16. 67%)(P〈0. 05). Expression level of OPN in group A was significantly correlated with tumor stage, grade and lymph node metastases(P〈0. 05). Expression level of COX-2 was significantly correlated with tumor stage and grade (P〈0. 05). OPN in group A was positively correlated with COX-2(P〈0. 05). Conclusion OPN and COX-2 may be the markers and potential therapeutic targets of supraglottic laryngeal squamous cell carcinomas.
出处 《江苏医药》 CAS 北大核心 2014年第9期1045-1047,共3页 Jiangsu Medical Journal
关键词 骨桥蛋白 环氧化酶2 声门上型喉癌 Osteopontin Cyclooxygenase-2 Supraglottic laryngeal squamous cell carcinoma
  • 相关文献

参考文献8

  • 1杨朋,康健.MTA1和KAI1蛋白在声门上型喉癌组织中的表达及其临床意义[J].江苏医药,2010,36(21):2518-2520. 被引量:5
  • 2Thorat D,Sahu A,Behera R,et al.Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers[J].Oncol Lett,2013,6(6):1559-1564.
  • 3徐鸥,李晓明,王茂鑫,屈永涛,路秀英,单春光,孙庆佳.组织缺氧诱导因子-1α及相关靶基因在喉鳞状细胞癌组织中的表达[J].中华耳鼻咽喉头颈外科杂志,2012,47(4):330-333. 被引量:5
  • 4Sun BS,Li Y,Zhang ZF,et al.Osteopontin combined with CD44v6,a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection[J].Ann Thorac Surg,2013,96(6):1943-1951.
  • 5Etiz D,Ataizi FC,Bayrnan E,et al.Prognostic value of osteopontin in patients treated with primary radiotherapy for head and neck cancer[J].Asian Pac J Cancer Prev,2013,14(9):5175-5178.
  • 6Celetti A,Testa D,Staibano S,et al.Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness[J].Clin Cancer Res,2005,11(22):8019-8027.
  • 7Celenk F,Bayramoglu I,Yilmaz A,et al.Expression of cyclooxygenase-2,12-lipoxygenase,and inducible nitric oxide synthase in head and neck squamous cell carcinoma[J].J Craniofac Surg,2013,24(4):1114-1117.
  • 8Tang H,Wang J,Bai F,et al.Positive correlation of osteo-pontin,cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer[J].Cancer Invest,2008,26(1):60-67.

二级参考文献15

  • 1Clark EA, Brugge JS. Integrins and signal transduction pathway: the road taken[J]. Science, 1995,268 (5208) : 233-239.
  • 2DongJT, Lamb PW, Rinker-Schaefer CW, et al. KAII,a metastasis suppressor gene for prostate cancer on human chromosome 11p11[J]. Science,1995,268(5212):884-886.
  • 3Dong JT, Isaacs WB, Barrett JC, et al. Genomic organization of the human KAIl metastasis-supperssor gene[J]. Genomics,1997,41(1) :25-32.
  • 4Miyazaki T, Kato H, Shitara Y, et al. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma[J]. Cancer,2000,89(5):955-962.
  • 5Imai Y,Sasaki T,Shinagawa Y,et al. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance[J]. Oral Oncol,2002,38(6) :557-561.
  • 6Toh Y, Pencil SD, Nicolson GL. Analysis of the complete sequence of the novel metastasis-associated candidate gene, mtal, differentially expressed in mammary adenocarcinoma and breast cancer cell lines[J]. Gene, 1995,159(1) : 97-104.
  • 7Nawa A, Nishimori k, Lin P, et al. Tumor ated human MTA1 gene:its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides[J]. J cell Biochem, 2000,79 (2) : 202-212.
  • 8Sasaki H, Moriyama S, Jakashima Y, et al. Expression of MTA1 mRNA in advanced lung cancer [J]. Lung Cancer, 2002,35(2): 149-154.
  • 9Qian H, Lu N, Xue I, et al. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line[J]. Clin Exp Metastasis, 2005,22 (8) : 653-662.
  • 10Hao ZL,Clifton S, Stephen, et al. Metastasis tumor antigen family protein during breast cancer progression and metastasis in a reliable mouse model for human breast cancer[J]. Clin Cancer Res, 2006,12 (5) : 1479-1486.

共引文献8

同被引文献13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部